医学信息2024，Vol.37Issue(11)：184-188,5.DOI:10.3969/j.issn.1006-1959.2024.11.039
左西孟旦应用于心脏手术的研究现状
Research Status of Levosimendan in Cardiac Surgery
李明前 1杨朝坤 2李彦君 2曹安2
作者信息
- 1. 成都医学院临床医学院,四川 成都 610000
- 2. 宜宾市第二人民医院胸心外科,四川 宜宾 644000
- 折叠
摘要
Abstract
Levosimendan is a new generation of positive inotropic drug that has great potential for use in cardiac surgery,as it avoids the risk of increased myocardial oxygen consumption associated with traditional cardiac drugs.Only some clinical studies have confirmed the benefits of levosimendan in cardiac surgery in terms of hemodynamics,blood test indexes,and hospital stay,while its advantages in terms of heart failure incidence and mortality have not surpassed those of traditional positive inotropic drugs.This article reviews the mechanism of action of levosimendan and its use in different time periods in the perioperative period of cardiac surgery to provide a reference for its clinical application.关键词
左西孟旦/作用机理/心脏手术Key words
Levosimendan/Mechanism of action/Cardiac surgery分类
医药卫生引用本文复制引用
李明前,杨朝坤,李彦君,曹安..左西孟旦应用于心脏手术的研究现状[J].医学信息,2024,37(11):184-188,5.
